Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Fischer-Valuck

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Prostate Cancer and Prostatic Diseases|November 14, 2020
Stereotactic body radiation therapy use for high risk prostate cancer in the United StatesSagar A Patel, Jeffrey M Switchenko, Amar U Kishan, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?Elizabeth Germino, Benjamin W Fischer-Valuck, Soumon Rudra, et al.
Tissue Engineering. Part A|March 6, 2009
Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cellsBonnie L Barrilleaux, Donald G Phinney, Benjamin W Fischer-Valuck, et al.
Thoracic Cancer|September 19, 2017
Influence of patient characteristics on survival following treatment with helical stereotactic body radiotherapy (SBRT) in stage I non-small-cell lung cancerBenjamin W Fischer-Valuck, Michael Durci, Sanford R Katz, et al.
Journal of Geriatric Oncology|September 26, 2021
Association of race with receipt of definitive therapy for high risk prostate cancer in older menSagar A Patel, Yuan Liu, Brandon A Mahal, et al.
Tumori|March 29, 2014
Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer CenterLane R Rosen, Benjamin W Fischer-Valuck, Sanford R Katz, et al.
Cureus|March 6, 2023
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation TherapyMichael R Waters, Neal Andruska, Benjamin W Fischer-Valuck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Practical Radiation Oncology|August 18, 2016
Magnetic resonance image guided radiation therapy for primary splenic diffuse large B-cell lymphoma: A teaching caseBenjamin W Fischer-Valuck, Olga Green, Thomas Mazur, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Prostate Cancer and Prostatic Diseases|November 14, 2020
Stereotactic body radiation therapy use for high risk prostate cancer in the United StatesSagar A Patel, Jeffrey M Switchenko, Amar U Kishan, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?Elizabeth Germino, Benjamin W Fischer-Valuck, Soumon Rudra, et al.
Tissue Engineering. Part A|March 6, 2009
Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cellsBonnie L Barrilleaux, Donald G Phinney, Benjamin W Fischer-Valuck, et al.
Thoracic Cancer|September 19, 2017
Influence of patient characteristics on survival following treatment with helical stereotactic body radiotherapy (SBRT) in stage I non-small-cell lung cancerBenjamin W Fischer-Valuck, Michael Durci, Sanford R Katz, et al.
Journal of Geriatric Oncology|September 26, 2021
Association of race with receipt of definitive therapy for high risk prostate cancer in older menSagar A Patel, Yuan Liu, Brandon A Mahal, et al.
Tumori|March 29, 2014
Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer CenterLane R Rosen, Benjamin W Fischer-Valuck, Sanford R Katz, et al.
Cureus|March 6, 2023
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation TherapyMichael R Waters, Neal Andruska, Benjamin W Fischer-Valuck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2022
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy AloneNeal Andruska, Benjamin W Fischer-Valuck, Ruben Carmona, et al.
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Practical Radiation Oncology|August 18, 2016
Magnetic resonance image guided radiation therapy for primary splenic diffuse large B-cell lymphoma: A teaching caseBenjamin W Fischer-Valuck, Olga Green, Thomas Mazur, et al.
Pageof 6